Am J Gastroenterol
- DANPANICHKUL P, Ng CH, Muthiah M, Suparan K, et al
From Shadows to Spotlight: Exploring the Escalating Burden of Alcohol-Associated
Liver Disease and Alcohol Use Disorder in Young Women.
Am J Gastroenterol. 2024;119:893-909.
- BAJAJ JS, Pimentel M
Is Hepatic Encephalopathy the First True Disorder of Gut-Brain interaction?
Am J Gastroenterol. 2024 Apr 22. doi: 10.14309/ajg.0000000000002824.
Am J Pathol
- HU J, Xu H, Ma X, Bai M, et al
Modulating PCGF4 Stability Is an Efficient Metastasis-Regulatory Strategy Used by
Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic
Cholangiocarcinoma.
Am J Pathol. 2024 Apr 24:S0002-9440(24)00160.
Anticancer Res
- WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for
Colorectal Liver Metastases (CRLM).
Anticancer Res. 2024;44:2177-2183.
- GON H, Komatsu S, Omiya S, Kido M, et al
The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular
Carcinoma Needing Repeat Liver Resection.
Anticancer Res. 2024;44:2031-2038.
- TSUNEMATSU M, Onda S, Shirai Y, Abe K, et al
Strategies to Perform Emergency Laparoscopic Partial Liver Resection for Ruptured
Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2171-2176.
- SEO SH, Yu JI, Park HC, Yoo GS, et al
Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for
Newly Diagnosed Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2219-2230.
- KOIZUMI A, Komatsu S, Omiya S, Yano Y, et al
Current Roles of Ramucirumab in the Sequential Treatment of Unresectable
Hepatocellular Carcinoma.
Anticancer Res. 2024;44:2055-2061.
- IKUTA S, Aihara T, Kasai M, Nakajima T, et al
Long-term Outcomes of Hepatic Resection Combined With Intraoperative Ablation
Versus Hepatic Resection Alone for Multinodular Hepatocellular Carcinoma:
Insights from a Single-center Study.
Anticancer Res. 2024;44:2133-2140.
- JUNG JY, Koh SA, Lee KH
Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated
Cell Proliferation and Metastasis in Gastric Cancer Cells.
Anticancer Res. 2024;44:1973-1981.
Biochem Biophys Res Commun
- HE L, Peng L, Wang L, Jiang X, et al
Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing
immunogenic cell death and damage-associated molecular patterns in hepatocellular
carcinoma.
Biochem Biophys Res Commun. 2024;714:149976.
- KIM DH, Kwon EJ, Park KG, Jin J, et al
Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic
degradation.
Biochem Biophys Res Commun. 2024;711:149921.
- YAMAMOTO T, Iizuka Y, Izumi-Yamamoto K, Shirota M, et al
Overexpression of Slc22a18 facilitates fat accumulation in mice.
Biochem Biophys Res Commun. 2024;712-713:149922.
BMC Cancer
- LI Y, Gong B, Guo Y, Liu W, et al
Non-small cell lung cancer and immune checkpoint inhibitor therapy: does
non-alcoholic fatty liver disease have an effect?
BMC Cancer. 2024;24:535.
- RAO L, Xu P, Zhang G, Zu R, et al
Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal
cancer patients after curative resection.
BMC Cancer. 2024;24:543.
- HUANG S, Liao Z, He X, Song Z, et al
Ethanol responsive lnc171 promotes migration and invasion of HCC cells via
mir-873-5p/ZEB1 axis.
BMC Cancer. 2024;24:550.
Cancer Res
- ZHANG R, Li S, Schippers K, Li Y, et al
Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That
Activate beta-Catenin Signaling.
Cancer Res. 2024;84:1443-1459.
Dig Dis Sci
- PEMMASANI G, Tremaine W, Karagozian R, John S, et al
Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
- THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in
Primary Care Patients.
Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
Gastroenterology
- WANG L, Berger NA, Kaelber DC, Xu R, et al
Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and
hepatic decompensation in patients with type 2 diabetes.
Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
Gut
- ROCA SUAREZ AA, Plissonnier ML, Grand X, Michelet M, et al
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and
impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.
Gut. 2024 May 2:gutjnl-2023-331396. doi: 10.1136/gutjnl-2023-331396.
- BREITKOPF-HEINLEIN K, Martinez-Chantar ML
Targeting hepatic stellate cells to combat liver fibrosis: where do we stand?
Gut. 2024 Apr 25:gutjnl-2023-331785. doi: 10.1136/gutjnl-2023-331785.
Hepatology
- CHOPRA SY, Rawat VL, Ingle MA, Lad SG, et al
Letter to Editor: Tranexamic acid in upper gastrointestinal bleed in patients
with cirrhosis - a randomized controlled trial.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000915.
- LI X, Zhang Y, Li S, Shi J, et al
Macrophage hitchhiking for systematic suppression in postablative multifocal
hepatocellular carcinoma.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000903.
- ELKRIEF L, Denecheau-Girard C, Magaz M, Praktiknjo M, et al
Abdominal surgery in patients with chronic noncirrhotic extra hepatic portal vein
obstruction: A multicenter retrospective study.
Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000901.
- KUMAR M, Venishetty S
Reply: Tranexamic acid in upper gastrointestinal bleed in patients with cirrhosis
- A randomized controlled trial.
Hepatology. 2024 Apr 30. doi: 10.1097/HEP.0000000000000916.
J Gastroenterol Hepatol
- ZHONG W, Xu B, Lu Y, Chang J, et al
Postoperative adjuvant chemotherapy is important for improving long-term survival
in patients with colorectal cancer liver metastases undergoing simultaneous
resection.
J Gastroenterol Hepatol. 2024;39:908-919.
- PEI X, Jiang W, Li L, Zeng Q, et al
Mendelian-randomization study revealed causal relationship between nonalcoholic
fatty liver disease and osteoporosis/fractures.
J Gastroenterol Hepatol. 2024;39:847-857.
- MAKRI ES, Evripidou K, Polyzos SA
Circulating leptin in patients with nonalcoholic fatty liver disease-related
liver fibrosis: a systematic review and a meta-analysis.
J Gastroenterol Hepatol. 2024;39:806-817.
- ENDO K, Kakisaka K, Abe T, Yusa K, et al
Positive impact of obesity on the prognosis of liver cirrhosis.
J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16590.
- LEE S, Choi J, Park JH, Lim CY, et al
Dynamic liver volume change in predicting hepatic decompensation and long-term
effects of stereotactic body radiation therapy.
J Gastroenterol Hepatol. 2024 May 2. doi: 10.1111/jgh.16588.
- QI S, Wei X, Zhao J, Wei X, et al
Performance of MAST, FAST, and MEFIB in predicting metabolic
dysfunction-associated steatohepatitis.
J Gastroenterol Hepatol. 2024 Apr 30. doi: 10.1111/jgh.16589.
- CAO QH, Liu H, Yan LJ, Wang HC, et al
Role of hepatitis B core-related antigen in predicting the occurrence and
recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A
systemic review and meta-analysis.
J Gastroenterol Hepatol. 2024 Apr 30. doi: 10.1111/jgh.16558.
J Hepatol
- FU JT, Liu J, Wu WB, Chen YT, et al
Targeting EFHD2 Inhibits Interferon-gamma Signaling and Ameliorates Non-Alcoholic
Steatohepatitis.
J Hepatol. 2024 Apr 24:S0168-8278(24)00277-0. doi: 10.1016/j.jhep.2024.
- MCGETTIGAN B, Shah V
EVERY SHERIFF NEEDS A DEPUTY: TARGETING NON-PARENCHYMAL CELLS TO TREAT HEPATIC
FIBROSIS.
J Hepatol. 2024 Apr 25:S0168-8278(24)00283-6. doi: 10.1016/j.jhep.2024.
- TAN MY, Su JH
Exploring Hepatocellular Carcinoma Risks in Sub-Saharan African and
Afro-Surinamese Individuals with Chronic Hepatitis B living in Europe.
J Hepatol. 2024 Apr 26:S0168-8278(24)00287-3. doi: 10.1016/j.jhep.2024.
- OLLIVIER-HOURMAND I, Lebedel L, Bartroli Alabau B, Goria O, et al
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with
non-cirrhotic portal vein thrombosis associated with local factors.
J Hepatol. 2024 Apr 26:S0168-8278(24)00284-8. doi: 10.1016/j.jhep.2024.
- YANG L, Niu K, Wang J, Shen W, et al
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis
via RNA splicing regulation of MADD.
J Hepatol. 2024 Apr 26:S0168-8278(24)00278-2. doi: 10.1016/j.jhep.2024.
N Engl J Med
- HARRISON SA, Taub R
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis. Reply.
N Engl J Med. 2024;390:1632-1633.
- SABET A
A Phase 3 Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med. 2024;390:1632.
PLoS One
- LIN YH, Zhang ZJ, Zhong JQ, Wang ZY, et al
Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty
liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
PLoS One. 2024;19:e0302155.
- BI CQ, Kang T, Qian YK, Kang M, et al
Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation
and xenograft tumor growth.
PLoS One. 2024;19:e0299522.
- BENGTSSON B, Maucourant C, Sandberg JK, Bjorkstrom NK, et al
Evaluation of mucosal-associated invariant T-cells as a potential biomarker to
predict infection risk in liver cirrhosis.
PLoS One. 2024;19:e0294695.
- YAMABA S, Imai Y, Sugawara K, Uchida Y, et al
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients
with unresectable hepatocellular carcinoma.
PLoS One. 2024;19:e0298770.
Radiology
- ZENG QQ, Liang P
Super-Resolution US Imaging of Focal Nodular Hyperplasia.
Radiology. 2024;311:e233130.
- CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis
Screening.
Radiology. 2024;311:e231461.
Transplant Proc
- KANG SW, Ban JY, Park MS
Protective Role of Rapamycin in Fibrotic Liver Ischemia/Reperfusion Injury
(C57bl/6 Mouse).
Transplant Proc. 2024;56:672-677.
- KANG HG, Park H, Myong GE, Kim WJ, et al
Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6
Mouse).
Transplant Proc. 2024;56:701-704.
- BEKKI T, Ohira M, Chogahara I, Imaoka K, et al
Association of Abdominal Aortic Calcification With the Postoperative Metabolic
Syndrome Components After Liver Transplantation.
Transplant Proc. 2024 Feb 7:S0041-1345(24)00016.
- SEO CH, Choi HJ, Na GH
Liver Transplantation at a Small Volume Center-The Role of Network System.
Transplant Proc. 2024 Feb 5:S0041-1345(24)00037.
Transplantation
- CONCORS SJ, Hernandez PT, O'Brien C, DePaolo J, et al
Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic
Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger
Ubiquitin-binding Domain.
Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005042.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016